As I think the current social media discussion isn't really raising any new points about the pros and cons of the MEGA study I have placed the following message on the MEA Facebook page
I would however be interested to read people's views on the question I pose - which is whether they would still want to stop this research dead in its tracks if it included the ME Biobank samples, including those with severe ME/CFS (who meet Canadian and Fukuda diagnostic criteria)
Message on MEA Facebook:
I don't think there is much point in continuing this CURRENT discussion on the OMEGA petition on MEA Facebook because:
1 All the key points in favour and against the MEGA study, based on our current state of knowledge of a protocol that is still being discused and developed, are now just being repeated
2 The internet discussion on MEA Facebook has been somewhat taken over by a small group of people who are very vocal both here, and elsewhere on the internet, in their very fixed opposition to OMEGA and the campaign to stop the study taking place - even though the protocol (ie design) of a complex piece of research is still being discussed and a patient liason group has not even met
Could I therefore move the discussion in a rather different direction and ask people one very simple question:
If the MEGA study were to include blood samples from the ME Biobank (part of the UCL Biobank) at the Royal Free Hospital in London - where we have collected blood samples (equating to over 30,000 aliquots now being stored) from over 500 people comprising a large group who have Canadian and Fukuda defined ME/CFS (including very detailed anonymised clinical information), healthy controls, and people with multiple sclerosis (where debilitating fatigue is a common feature) - would you still want to stop the MEGA study taking place?
Or do you really want to stop this research dead in its tracks right now and say to the distinguished group of biomedical research scientists (listed below) that have been recruited over the past year or so (like Professor Chris Ponting) that their expertise and enthusiasm for getting involved in ME/CFS research is not now required - so they can take their expertise and enthusiasm to some other disease where the patient community would welcome their input
* Genomics – Prof George Davey-Smith (Bristol), Prof Chris Ponting (Edinburgh), Prof Colin Smith (Brighton)
* Epigenetics – Prof Caroline Relton (Bristol)
* Proteomics – Mr Tony Bartlett (Somalogic)
* Metabolomics – Dr Rick Dunn (Birmingham)
* Routinely collected data – Prof Andrew Morris (Edinburgh) and Prof David Ford (Swansea)
* Infection – Prof Paul Moss (Birmingham)
* Sleep – Prof Jim Horne (Loughborough)
* Pain – Prof Maria Fitzgerald (UCL)
* Prof Julia Newton (Newcastle)
I obviously have both a personal and professional interest in trying to find an objective way of diagnosing this illness (and separating it from other causes of chronic fatigue and ME/CFS like symptoms), what causes it and how it can be effectively treated
I have no interest in pursuing psychiatric research into this illness and do not support money being spent of psychiatric research or behavioural interventions
But I really do find it depressing to see that people are being asked to oppose this research on the basis that the use of various types of -omics to look for biomarkers associated with clinical phenotypes (ie sub-groups) of ME/CFS is psychiatric research when this is clearly not the case
Dr Charles Shepherd
Hon Medical Adviser, MEA
ME Biobank:
http://cureme.lshtm.ac.uk